We made animal model of pulmonary fibrosis with bleomycin. We found LXRs agonist T0901317 can attenuate bleomycin induced pulmonary fibrosis. After bleomycin treatment, T0901317 can inhibit expression of cytokines and TGF-β1. T0901317 can also inhibit NF-κB activity and I κBα degradation.